Science_TechSocial_Issues
News 0 of 32

ICMR i-DRONE Initiative in Telangana Cuts TB Diagnosis Time by 10 Days, Cost from Rs 9,451 to Rs 91

Target:UPSC GS-IIIMPSCSSC GATeachingPrelims HighMains MediumStatic GK Link
16 Jul 2026
~2 min
Source: Indian Express
Key Data:16.6 days to 6.9 daysRs 9,451 to Rs 91Same-day results: 6.3% to 7.4%Next-day results: 1.5% to 76.3%Two-day delays: 92.2% to 16.3%
Bodies:ICMR
Practice MCQs from today's news ▸
What This Article Covers

1.ICMR pilot in Telangana shows drones reduce TB diagnosis time by ~10 days (16.6 to 6.9 days) and cost from Rs 9,451 to Rs 91.

2.The i-DRONE initiative used hub-and-spoke drone network connecting 60 sub-centres, 11 PHCs, and 4 TB units.

3.Proportion of patients receiving results next day increased from 1.5% to 76.3%, highlighting potential for rural healthcare.

The Big Picture
Prelims · HighMains · Medium

ICMR study in Telangana demonstrates that drones can drastically reduce TB diagnosis time from 16.6 to 6.9 days and cut patient out-of-pocket expenditure from Rs 9,451 to Rs 91. The i-DRONE initiative uses hub-and-spoke drone network to transport sputum samples, bypassing geographical barriers. This is crucial for India's goal to eliminate TB by 2030, especially in remote areas.

Exam Lens

Quick Exam Facts From News

Diagnosis Time Reduction16.6 days to 6.9 days
Cost ReductionRs 9,451 to Rs 91
Next-Day Results Increase1.5% to 76.3%
Drone Payloads2 kg (11.5 kg drone) and 8 kg (24 kg drone)

1-Minute Revision

  • ›Diagnosis Time Reduction: 16.6 days to 6.9 days
  • ›Cost Reduction: Rs 9,451 to Rs 91
  • ›Target this Data: Diagnosis time reduced from 16.6 to 6.9 days; cost from Rs 9,451 to Rs 91
  • ›Target this Initiative: i-DRONE initiative by ICMR in Telangana
  • ›Target this Goal: TB elimination by 2030 (India missed 2025 deadline)

Mastered this topic? Test your knowledge with a full MCQ quiz.

Practice exam-style questions, track your score, and strengthen your recall.

Q1Static LinkageEasy

Which organization conducted the study on using drones for TB diagnosis in Telangana?

Q2Statement-basedHard

Consider the following statements regarding the i-DRONE initiative:

1. The initiative used a hub-and-spoke network between sub-centres, primary health centres, and TB units in Telangana.

2. The initiative reduced the average cost of TB diagnosis from Rs 9,451 to Rs 91.

3. The proportion of patients receiving results on the same day increased from 6.3% to 76.3% after using drones.

Which of the statements given above is/are correct?

Q3Data-centricMedium

According to the ICMR study, what was the average time to receive a TB diagnosis before the i-DRONE initiative?

Q4Application/ImpactMedium

What is the primary objective of the i-DRONE initiative as described in the article?

All 25 MCQs ▸
You finished this topic
Explore Related Topics
Related Current Affairs
Science & Tech Current Affairs

Proposed Patient Data Collective (PDC) Model for Rare Diseases in India Inspired by Amul Cooperative

A new proposal suggests creating a Patient Data Collective (PDC) for rare diseases in India, modeled on the Amul dairy cooperative. This collective would pool patient data to accelerate drug discovery and clinical trials, addressing the challenge of small patient populations for rare diseases.

Science & Tech Current Affairs

ICMR Study: 61% Gram-Negative Infections Carbapenem-Resistant; Mortality 39-51%

A large ICMR study across 20 Indian hospitals (2022-2025) reveals that carbapenem-resistant Gram-negative infections cause significantly higher mortality (39-51% in bloodstream infections) and cost 1.1-2 times more to treat. The study stresses that antimicrobial resistance is a complex interplay of healthcare transmission, antibiotic pressure, and diagnostic gaps, not just antibiotic overuse.

Social Issues Current Affairs

VP Launches India Valve Registry for Heart Valve Disease Research; TN Reports 2,590 Valve Replacements in 20 Months

The Vice-President launched the India Valve Registry, a first-of-its-kind clinician-led platform to collect real-world data on valvular heart disease and interventions in India. The registry will generate India-specific evidence to improve patient care, while Tamil Nadu's CMCHIS data reveals 2,590 valve replacements in 20 months, highlighting the burden of rheumatic heart disease and the success of state-led healthcare.

Polity Current Affairs

MeitY Summons Meta Global Team Over Algorithmic Bias; Parliamentary Panel to Question

Government summons Meta's global team to clarify algorithmic bias and role in public order after MeitY rejects technical glitch explanation. Parliamentary panel will also question the company. This highlights growing regulatory scrutiny on social media algorithms and their societal impact.

Science & Tech Current Affairs

India Gets First Disease-Modifying Alzheimer's Drug Leqembi After CDSCO Nod

Eisai's Leqembi (lecanemab), India's first disease-modifying therapy for early Alzheimer's, has been launched after CDSCO approval. This marks a shift from symptomatic to disease-modifying treatment, but challenges of early diagnosis, biomarker infrastructure, and affordability remain significant.

Social Issues Current Affairs

NOTTO Reports 20,000+ Transplants in 2025, Launches Portal and Swap Guidelines

NOTTO released 2025 data showing over 20,000 transplants, persistent gender disparity in organ donation (68% female donors vs 78% male recipients), and launched a new digital portal to enhance transparency. New swap transplantation guidelines aim to expand matching beyond single hospitals, but legal recognition under THOTA is still pending.

Science & Tech Current Affairs

IARC Classifies Three WHO Essential Medicines as Group 1 Carcinogens: Hydrochlorothiazide, Voriconazole, Tacrolimus

IARC, the WHO cancer research agency, has classified three widely used drugs—hydrochlorothiazide, voriconazole, and tacrolimus—as Group 1 carcinogens. Despite this, experts stress that patients should not stop treatment as the benefits for hypertension, fungal infections, and organ transplant rejection far outweigh the cancer risk. The drugs are on the WHO Model List of Essential Medicines and are commonly prescribed in India.

Science & Tech Current Affairs

IISc SraVaani: India's First Open-Source Speech Recognition Model for 65 Languages

IISc's SPIRE Lab, in collaboration with ARTPARK and Google, has released SraVaani – the first multilingual Indian speech recognition model trained on 65 languages and dialects. It extends ASR to 45 underserved regional languages, potentially benefiting 25 crore people. This marks a major step in inclusive AI for India's linguistic diversity.